Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04169724 · ClinicalTrials.gov registry record · NA

Meditation for Burnout in PA Students

A NA study, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT04169724: Completed NA study, sponsored by Arizona State University.

NCT04169724 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04169724, a NA study, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

This study investigates the feasibility and effects of an app-based mindfulness meditation intervention for PA students.

Primary Outcome

The Maslach Burnout Inventory is a 22-item inventory used to measure aspects of the burnout syndrome within three subscales: emotional exhaustion, depersonalization, and personal accomplishment. Using a seven-point scale (0, never; 1, a few times per year; 2, once a month; 3, a few times a month; 4, once a week; 5, a few times a week; 6, every day), participants rate their experience of burnout. Possible scores on the emotional exhaustion subscale range from 0 to 54. Possible scores on the deper

Interventions

  • BEHAVIORAL Calm Meditation

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2019-09-30
Est. Completion 2020-03-09
Phase NA
Arizona State University

187 total trials

What the finished NCT04169724 record still lists

NCT04169724 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Calm Meditation is the first listed.

NCT04169724 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04169724 about?

NCT04169724 is a clinical study titled "Meditation for Burnout in PA Students". This study investigates the feasibility and effects of an app-based mindfulness meditation intervention for PA students.

What is the current status of trial NCT04169724?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-09-30. Estimated completion is 2020-03-09.

What interventions are being tested in trial NCT04169724?

The interventions under investigation include: Calm Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04169724?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04169724's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04169724, the US trial registry maintained by the National Library of Medicine. NCT04169724 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.